Safety Alerts for Human Medical Products > Risks Associated with Use of Rupture of Membranes Tests - Letter to Health Care Providers

Safety Alerts for Human Medical Products > Risks Associated with Use of Rupture of Membranes Tests - Letter to Health Care Providers

A new MedWatch Safety Alert: Risks Associated with Use of Rupture of Membranes Tests - Letter to Health Care Providers intended for: OBGYN, Risk Manager, Health Professional was just added to the FDA MedWatch Webpage.

 

You can read the complete MedWatch Safety Alert that includes recommendations at: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm616220.htm